CN108142939A - 一种含胎盘干细胞因子的口服液及其制备方法 - Google Patents
一种含胎盘干细胞因子的口服液及其制备方法 Download PDFInfo
- Publication number
- CN108142939A CN108142939A CN201810109973.7A CN201810109973A CN108142939A CN 108142939 A CN108142939 A CN 108142939A CN 201810109973 A CN201810109973 A CN 201810109973A CN 108142939 A CN108142939 A CN 108142939A
- Authority
- CN
- China
- Prior art keywords
- amnion
- chorion
- oral liquid
- cell
- placenta stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002826 placenta Anatomy 0.000 title claims abstract description 51
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 50
- 239000007788 liquid Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 210000001691 amnion Anatomy 0.000 claims abstract description 62
- 210000001136 chorion Anatomy 0.000 claims abstract description 52
- 239000000463 material Substances 0.000 claims abstract description 18
- 238000012545 processing Methods 0.000 claims abstract description 18
- 210000001519 tissue Anatomy 0.000 claims abstract description 18
- 239000002253 acid Substances 0.000 claims abstract description 17
- 238000005336 cracking Methods 0.000 claims abstract description 17
- 238000004458 analytical method Methods 0.000 claims abstract description 11
- 238000004945 emulsification Methods 0.000 claims abstract description 11
- 241001465754 Metazoa Species 0.000 claims abstract description 10
- 230000001954 sterilising effect Effects 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000006166 lysate Substances 0.000 claims abstract description 6
- 230000014759 maintenance of location Effects 0.000 claims abstract description 3
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 238000004140 cleaning Methods 0.000 claims description 14
- 238000002965 ELISA Methods 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 238000007689 inspection Methods 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 241001494479 Pecora Species 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 230000009977 dual effect Effects 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 5
- 210000004379 membrane Anatomy 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 239000008215 water for injection Substances 0.000 claims description 5
- 241000283707 Capra Species 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 230000020477 pH reduction Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 229930182555 Penicillin Natural products 0.000 claims description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 229940049954 penicillin Drugs 0.000 claims description 3
- 238000005554 pickling Methods 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 2
- 241000282994 Cervidae Species 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 241000628997 Flos Species 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 239000002552 dosage form Substances 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 description 10
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000008588 hemolysis Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000011132 hemopoiesis Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000005059 placental tissue Anatomy 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 2
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 244000144992 flock Species 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 206010024328 Leukaemoid reaction Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 210000005151 decidua basalis Anatomy 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810109973.7A CN108142939A (zh) | 2018-02-05 | 2018-02-05 | 一种含胎盘干细胞因子的口服液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810109973.7A CN108142939A (zh) | 2018-02-05 | 2018-02-05 | 一种含胎盘干细胞因子的口服液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108142939A true CN108142939A (zh) | 2018-06-12 |
Family
ID=62456924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810109973.7A Pending CN108142939A (zh) | 2018-02-05 | 2018-02-05 | 一种含胎盘干细胞因子的口服液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108142939A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1145196A (zh) * | 1995-01-24 | 1997-03-19 | 郭金刚 | 胎盘肽口服液及其制造方法 |
CN1537465A (zh) * | 2003-10-14 | 2004-10-20 | 大连轻工学院 | 羊胎盘功能性食品及其制备方法 |
CN1965863A (zh) * | 2006-11-07 | 2007-05-23 | 内蒙古神元生物工程股份有限公司 | 制备动物胎盘兽用复方氨基酸口服液的方法 |
CN101028286A (zh) * | 2006-03-01 | 2007-09-05 | 红原牦牛肉食品有限责任公司 | 羊胎盘提取物及其制备方法 |
CN103408634A (zh) * | 2013-07-16 | 2013-11-27 | 新疆医科大学 | 马胎盘水溶性蛋白提取物及其制备方法和应用 |
-
2018
- 2018-02-05 CN CN201810109973.7A patent/CN108142939A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1145196A (zh) * | 1995-01-24 | 1997-03-19 | 郭金刚 | 胎盘肽口服液及其制造方法 |
CN1537465A (zh) * | 2003-10-14 | 2004-10-20 | 大连轻工学院 | 羊胎盘功能性食品及其制备方法 |
CN101028286A (zh) * | 2006-03-01 | 2007-09-05 | 红原牦牛肉食品有限责任公司 | 羊胎盘提取物及其制备方法 |
CN1965863A (zh) * | 2006-11-07 | 2007-05-23 | 内蒙古神元生物工程股份有限公司 | 制备动物胎盘兽用复方氨基酸口服液的方法 |
CN103408634A (zh) * | 2013-07-16 | 2013-11-27 | 新疆医科大学 | 马胎盘水溶性蛋白提取物及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
李飞等: "《大学生安全教育点对点》", 30 September 2013, 上海浦江教育出版社 * |
王秉栋: "《动物性食品卫生理化检验》", 31 October 1994, 中国农业出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Swatland | Structure and development of meat animals and poultry | |
DE69727332T2 (de) | Zubereitungen enthaltend Kollagen, Vitamin D3 und Kalzium zur Verstärkung des Knochens | |
Luechtefeld et al. | Campylobacter fetus subsp. jejuni in a turkey processing plant | |
CN106255421A (zh) | 大蒜发酵组合物的制造方法及大蒜发酵组合物 | |
Larsen et al. | Impact of commercial preharvest transportation and holding on the prevalence of Salmonella enterica in cull sows | |
CN103550543B (zh) | 一种治疗仔猪腹泻的中药及其制备方法 | |
CN109430368A (zh) | 联合乳酸菌抑菌液淋洗以进行牛肉胴体消毒的多元化方法 | |
CN108142939A (zh) | 一种含胎盘干细胞因子的口服液及其制备方法 | |
Laster et al. | Efficacy of trimming chilled beef during fabrication to control Escherichia coli O157: H7 surrogates on subsequent subprimals | |
Balakirev et al. | Ensuring health, safety, and realization of productive qualities of pigs by immunotropic preparations | |
CN105875292A (zh) | 卵磷脂结合葡萄汁有孢汉逊酵母防治柑橘采后病害的方法 | |
CN107595758A (zh) | 一种羊膜乳液制备方法、羊膜乳液胶联面膜及其制备方法 | |
CN106574247A (zh) | 从全血中扩增成体干细胞的方法 | |
Sultana et al. | Black quarter (BQ) disease in cattle and diagnosis of BQ septicaemia based on gross lesions and microscopic examination | |
Knivett et al. | Comparison of oral vaccination or furazolidone prophylaxis for Salmonella typhimurium infection in chicks | |
Al-Salihi | Observations on dromedary Arabian camel) and its diseases | |
CN106075407B (zh) | 一种功能性钙制剂及其制备方法 | |
Ratsep | Kid mortality on Ontario goat farms | |
Hesham et al. | Prevalence of Listeria spp. among dairy, meat and their products marketed in Tripoli, Libya | |
Hayes | Validation of thermal destruction of pathogenic bacteria in rendered animal products | |
Round | Contributions to the bacteriology of the oyster: The results of experiments and observations made while conducting an investigation directed and authorized by the commissioners of shell fisheries of the state of Rhode Island | |
Saad et al. | Bacteriological profile of sheep carcasses in a private Egyptian abattoir | |
CN108158841A (zh) | 鹌鹑蛋活性成分ovoinhibitor糖蛋白在抗过敏中的应用 | |
Fredianto et al. | Sea cucumber as an alternative supplement in increasing bone health | |
Mohammed et al. | EFFECTIVE MICROBIAL SUPPLIMENTATION IN THE DIET OF BEEF CATTLE AND ITS EFFECT ON SALMONELLA BURDEN AND ITS FOOD SAFETY IMPLICATION: A CASE OF CHERCHER ODA BULTUM UNION FARM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 010000 Tower 2, Tengfei Commercial Plaza, Kezhen, Wuchuan County, Hohhot City, Inner Mongolia Autonomous Region Applicant after: Inner Mongolia Shen Yuan Kang peptide Bioengineering Co., Ltd. Address before: 010000 Tower 2, Tengfei Commercial Plaza, Kezhen, Wuchuan County, Hohhot City, Inner Mongolia Autonomous Region Applicant before: Inner Mongolia Kang peptide Bioengineering Co., Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 010000 Business Incubation Park of Wuchuan County, Hohhot City, Inner Mongolia Autonomous Region 302-303 (West Building of Agricultural Bank of Wuchuan Kezhen) Applicant after: Inner Mongolia Yudonkey Kangdi Bioengineering Co., Ltd. Address before: 010000 Tower 2, Tengfei Commercial Plaza, Kezhen, Wuchuan County, Hohhot City, Inner Mongolia Autonomous Region Applicant before: Inner Mongolia Shen Yuan Kang peptide Bioengineering Co., Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 010000 Business Incubation Park of Wuchuan County, Hohhot City, Inner Mongolia Autonomous Region 302-303 (West Building of Agricultural Bank of Wuchuan Kezhen) Applicant after: Inner Mongolia Yuanben Biomedical Technology Co., Ltd Address before: 010000 Business Incubation Park of Wuchuan County, Hohhot City, Inner Mongolia Autonomous Region 302-303 (West Building of Agricultural Bank of Wuchuan Kezhen) Applicant before: Inner Mongolia Yudonkey Kangdi Bioengineering Co., Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180612 |